Publication productivity of authors of psoriasis clinical practice guidelines with and without ties to industry - 11/10/19
Doi : 10.1016/j.jaad.2019.06.001
Sree S. Kolli, BA a, ⁎ 
, William W. Huang, MD, MPH a, Steven R. Feldman, MD, PhD a, b, c
, William W. Huang, MD, MPH a, Steven R. Feldman, MD, PhD a, b, c a Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina
b Department of Pathology, Wake Forest School of Medicine, Winston-Salem, North Carolina
c Department of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina
∗Reprint requests: Sree S. Kolli, BA, Department of Dermatology, Wake Forest School of Medicine, 1 Medical Center Blvd, Winston-Salem, NC 27157-1071Department of DermatologyWake Forest School of Medicine1 Medical Center BlvdWinston-SalemNC27157-1071
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Friday 11 October 2019
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
| Funding sources: None. |
|
| Conflicts of interest: Dr Feldman is a speaker for Janssen and Taro; consultant and speaker for Galderma, Stiefel/GlaxoSmithKline, Abbott Labs, and Leo Pharma Inc; and consultant for Amgen, Baxter, Caremark, Gerson Lehrman Group, Guidepoint Global, Hanall Pharmaceutical Co Ltd, Kikaku, Lilly, Merck & Co Inc, Merz Pharmaceuticals, Mylan, Novartis Pharmaceuticals, Pfizer Inc, Qurient, Suncare Research, and Xenoport. He has received grants from Galderma, Janssen, Abbott Labs, Amgen, Celgene, Stiefel/GlaxoSmithKline, and Anacor and is on an advisory board for Pfizer Inc. Dr Feldman is the founder and holds stock in Causa Research and holds stock and is a majority owner of Medical Quality Enhancement Corporation. He also receives Royalties from UpToDate and Xlibris. Ms Kolli and Dr Huang have no conflicts of interest to disclose. |
© 2019
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?